Ignite Creation Date:
2025-12-25 @ 3:44 AM
Ignite Modification Date:
2026-03-02 @ 4:01 PM
Study NCT ID:
NCT02876302
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-08-19
First Post:
2016-08-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study Of Ruxolitinib (INCB018424) With Preoperative Chemotherapy For Triple Negative Inflammatory Breast Cancer
Sponsor:
Dana-Farber Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-01-24
Start Date Type:
ACTUAL
Primary Completion Date:
2022-12-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-12
Completion Date Type:
ESTIMATED
First Submit Date:
2016-08-09
First Submit QC Date:
None
Study First Post Date:
2016-08-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2023-12-19
Results First Submit QC Date:
None
Results First Post Date:
2024-04-18
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-05
Last Update Post Date:
2025-08-19
Last Update Post Date Type:
ACTUAL